Value Analysis of Insulin Aspartate 30 Combined with Metformin in Treat-ment of Newly Diagnosed Type 2 Diabetes in Elderly Patients
Objective To analyze the therapeutic effect of insulin aspartate 30 combined with metformin in elderly pa-tients with newly diagnosed type 2 diabetes.Methods A total of 68 elderly patients with newly diagnosed type 2 diabe-tes treated in Daqing People's Hospital from April to July 2023 were non-randomly selected as the study objects.The patients were divided into control group(n=34)and study group(n=34)with different treatment methods.The control group was treated with insulin aspartate 30 injection.The study group was treated with insulin aspartate 30 combined with metformin,and the clinical efficacy,levels of inflammatory factors and incidence of adverse reactions were com-pared between the two groups.Results The effective rate of the study group was 97.06%(33/34),better than 85.29%(29/34)of the control group,the difference was statistically significant(χ2=8.675,P<0.05).Blood glucose and blood lipid levels of the study group were significantly better than those of the control group,and the differences were statis-tically significant(all P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Insulin aspartate 30 combined with metformin has good efficacy in elderly patients with newly diagnosed type 2 diabetes,and can reduce the blood glucose level and the incidence of adverse reactions.
Insulin aspartate 30MetforminNewly diagnosed type 2 diabetes in the elderlyValue
万方数据
维普
